iGMDRD66
Standard Name | CHEMBL | Pubchem CID | KEGG Drug ID | DRUGBANK ID | Drug Status | Drug targets (TTD) | Drug Type |
---|---|---|---|---|---|---|---|
Doxorubicin | CHEMBL53463 CHEMBL216371 CHEMBL272706 CHEMBL359744 | 31703 | D03899 | DB00997 | Alone | DNC000163 | Small Molecule |
Drug Class:
Anthracycline Topoisomerase InhibitorAnthracyclinesAnthracyclines and Related SubstancesAntibiotics, AntineoplasticAntineoplastic AgentsAntineoplastic and Immunomodulating AgentsBCRP/ABCG2 SubstratesCarbohydratesCardiotoxic antineoplastic agentsCytochrome P-450 Enzyme InhibitorsCytotoxic Antibiotics and Related SubstancesDaunorubicinEnzyme InhibitorsGlycosidesHydrocarbonsHydrocarbons, AromaticHydrocarbons, CyclicImmunosuppressive AgentsMyelosuppressive AgentsNaphthacenesP-glycoprotein/ABCB1 InducersP-glycoprotein/ABCB1 SubstratesPolycyclic CompoundsPolycyclic Hydrocarbons, AromaticTopoisomerase II InhibitorsTopoisomerase InhibitorsDrug Pathways:
DNA replicationBiosynthesis of type II polyketide products Biosynthesis of antibioticsDrug-model tissue-cancer distribution: Bubble Plot
Drug-gene pathway enrichments
Drug-gene GO enrichments
Drug-Gene: Aster Plot
Gene ID | Gene Name | Model Num. |
---|---|---|
7514 | XPO1 | 1 |
5295 | PIK3R1 | 1 |
83481 | EPPK1 | 2 |
4170 | MCL1 | 2 |
11200 | CHEK2 | 1 |
5159 | PDGFRB | 1 |
27065 | NSG1 | 1 |
983 | CDK1 | 1 |
27332 | ZNF638 | 1 |
7157 | TP53 | 7 |
6714 | SRC | 1 |
3791 | KDR | 1 |
4086 | SMAD1 | 1 |
54658 | UGT1A1 | 1 |
4609 | MYC | 1 |
6935 | ZEB1 | 2 |
7153 | TOP2A | 1 |
2648 | KAT2A | 2 |
7248 | TSC1 | 1 |
53353 | LRP1B | 3 |
100862685 | ERVK-19 | 1 |
5925 | RB1 | 1 |
4893 | NRAS | 1 |
7040 | TGFB1 | 1 |
Gene in drug-gene network: Network Plot
Models in Doxorubicin